| Implications of asymptomatic carriers for infectious disease transmission and control RH Chisholm, PT Campbell, Y Wu, SYC Tong, J McVernon, N Geard Royal Society open science 5 (2), 172341, 2018 | 80 | 2018 |
| An economic case for a vaccine to prevent group A streptococcus skin infections JW Cannon, S Jack, Y Wu, J Zhang, MG Baker, E Geelhoed, J Fraser, ... Vaccine 36 (46), 6968-6978, 2018 | 48 | 2018 |
| Dynamics of bacterial insertion sequences: can transposition bursts help the elements persist? Y Wu, RZ Aandahl, MM Tanaka BMC evolutionary biology 15 (1), 1-12, 2015 | 36 | 2015 |
| Predicting the causative pathogen among children with osteomyelitis using Bayesian networks–improving antibiotic selection in clinical practice Y Wu, C McLeod, C Blyth, A Bowen, A Martin, A Nicholson, S Mascaro, ... Artificial Intelligence in Medicine 107, 101895, 2020 | 19 | 2020 |
| Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling Y Wu, J Wood, G Khandaker, C Waddington, T Snelling Vaccine 34 (46), 5636-5642, 2016 | 17 | 2016 |
| Dynamics of evolutionary rescue in changing environments and the emergence of antibiotic resistance Y Wu, CA Saddler, F Valckenborgh, MM Tanaka Journal of Theoretical Biology 340, 222-231, 2014 | 16 | 2014 |
| Identification of the determinants of incomplete vaccination in Australian children C Lim, GE Currie, CS Waddington, Y Wu, S Setijo, J Leask, JA Marsh, ... Vaccine: X 1, 100010, 2019 | 15 | 2019 |
| Urinary tract infections in children: building a causal model-based decision support tool for diagnosis with domain knowledge and prospective data JA Ramsay, S Mascaro, AJ Campbell, DA Foley, AO Mace, P Ingram, ... BMC Medical Research Methodology 22 (1), 1-17, 2022 | 13 | 2022 |
| Epidemiological control of drug resistance and compensatory mutation under resistance testing and second-line therapy CA Saddler, Y Wu, F Valckenborgh, MM Tanaka Epidemics 5 (4), 164-173, 2013 | 10 | 2013 |
| Estimation of the force of infection and infectious period of skin sores in remote Australian communities using interval-censored data MJ Lydeamore, PT Campbell, DJ Price, Y Wu, AJ Marcato, W Cuningham, ... PLoS computational biology 16 (10), e1007838, 2020 | 9 | 2020 |
| Coverage gaps in empiric antibiotic regimens used to treat serious bacterial infections in neonates and children in Southeast Asia and the Pacific PCM Williams, M Jones, TL Snelling, R Duguid, N Moore, B Dickson, ... The Lancet Regional Health-Southeast Asia, 2023 | 8 | 2023 |
| The influence of incomplete case ascertainment on measures of vaccine efficacy Y Wu, JA Marsh, ES McBryde, TL Snelling Vaccine 36 (21), 2946-2952, 2018 | 8 | 2018 |
| Predicting the causative pathogen among children with pneumonia using a causal Bayesian network Y Wu, S Mascaro, M Bhuiyan, P Fathima, AO Mace, MP Nicol, ... PLoS Comput Biol 19 (3), e1010967, 2023 | 7 | 2023 |
| Bridging the gaps in test interpretation of SARS-CoV-2 through Bayesian network modelling Y Wu, D Foley, J Ramsay, O Woodberry, S Mascaro, AE Nicholson, ... Epidemiology & Infection 149, 2021 | 7 | 2021 |
| A model of population dynamics with complex household structure and mobility: implications for transmission and control of communicable diseases RH Chisholm, B Crammond, Y Wu, AC Bowen, PT Campbell, SYC Tong, ... PeerJ 8, e10203, 2020 | 6 | 2020 |
| Burden of congenital rubella syndrome (Crs) in Bangladesh: Systematic review of existing literature and transmission modelling of seroprevalence studies J Chan, Y Wu, J Wood, M Muhit, MK Mahmood, T Karim, F Moushumi, ... Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2020 | 6 | 2020 |
| Modeling COVID-19 disease processes by remote elicitation of causal Bayesian networks from medical experts S Mascaro, Y Wu, O Woodberry, EP Nyberg, R Pearson, JA Ramsay, ... BMC Medical Research Methodology 23 (76), 2023 | 5 | 2023 |
| Preferred health outcome states following treatment for pulmonary exacerbations of cystic fibrosis C McLeod, J Wood, S Mulrennan, S Morey, A Schultz, M Messer, ... Journal of Cystic Fibrosis, 2022 | 4 | 2022 |
| Novel method to select meaningful outcomes for evaluation in clinical trials C McLeod, R Norman, J Wood, S Mulrennan, S Morey, A Schultz, ... BMJ Open Respiratory Research 8 (1), e000877, 2021 | 4 | 2021 |
| Perinatal risk factors associated with skin infection hospitalisation in Western Australian Aboriginal and Non‐Aboriginal children R Barnes, AC Bowen, R Walker, SYC Tong, J McVernon, PT Campbell, ... Paediatric and perinatal epidemiology 33 (5), 374-383, 2019 | 3 | 2019 |
